These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2526591)

  • 1. Effect of ANP on circulating blood volume.
    Sugimoto E; Shigemi K; Okuno T; Yawata T; Morimoto T
    Am J Physiol; 1989 Jul; 257(1 Pt 2):R127-31. PubMed ID: 2526591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of decreased cardiac output during ANP infusion in conscious anephric dogs.
    Mizelle HL; Gaillard CA; Manning RD; Hall JE
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R120-5. PubMed ID: 1531105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
    Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
    Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted effect of ANP on hematocrit and plasma volume in streptozotocin-induced diabetes mellitus in rats.
    Valentin JP; Sechi LA; Humphreys MH
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R584-91. PubMed ID: 8141419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
    Hansell P; Fasching A; Sjöquist M; Andén NE; Ulfendahl HR
    Acta Physiol Scand; 1987 Jul; 130(3):401-7. PubMed ID: 2957892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atrial natriuretic peptide (ANP) during converting enzyme inhibition.
    Hansell P; Ulfendahl HR
    Acta Physiol Scand; 1987 Jul; 130(3):393-9. PubMed ID: 2957891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of atrial natriuretic peptide in natriuresis in volume-expanded rats.
    Kaneko K; Okada K; Ishikawa S; Kuzuya T; Saito T
    Am J Physiol; 1987 Dec; 253(6 Pt 2):R877-82. PubMed ID: 2962511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of chronic infusion of rANP in renal hypertensive rats.
    Fenoy FJ; Quesada T; García-Salom M; Romero JC; Salazar FJ
    Am J Physiol; 1989 May; 256(5 Pt 2):H1393-8. PubMed ID: 2524171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone effects on transcapillary fluid dynamics.
    Stachenfeld NS; Keefe DL; Palter SF
    Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1319-29. PubMed ID: 11557642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic response to hypervolemia is absent in rats with papillary necrosis.
    Keeler R; Wilson N
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R422-6. PubMed ID: 2527476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atrial natriuretic peptide (ANP) on jejunal net fluid absorption in the rat.
    Pettersson A; Jönsson CO
    Acta Physiol Scand; 1989 Jul; 136(3):419-26. PubMed ID: 2526450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats.
    Almeida FA; Suzuki M; Maack T
    Life Sci; 1986 Sep; 39(13):1193-9. PubMed ID: 2943959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic atrial natriuretic peptide reduces human leg capillary filtration.
    Watenpaugh DE; Vissing SF; Lane LD; Buckey JC; Firth BG; Erdman W; Hargens AR; Blomqvist CG
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):414-9. PubMed ID: 8583783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of atrial natriuretic peptide in systemic responses to acute isotonic volume expansion.
    Watenpaugh DE; Yancy CW; Buckey JC; Lane LD; Hargens AR; Blomqvist CG
    J Appl Physiol (1985); 1992 Oct; 73(4):1218-26. PubMed ID: 1447062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependence and reversibility of the hemoconcentrating and hypotensive activities of atrial natriuretic peptide in binephrectomized rats.
    Valentin JP; Sechi LA
    Fundam Clin Pharmacol; 1994; 8(3):238-45. PubMed ID: 7927119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide augments forearm capillary filtration in humans.
    Groban L; Cowley AW; Ebert TJ
    Am J Physiol; 1990 Jul; 259(1 Pt 2):H258-63. PubMed ID: 2142858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide in rats with experimental cirrhosis of the liver without ascites.
    Olivera A; Gutkowska J; Rodriguez-Puyol D; Fernandez-Cruz A; López-Novoa JM
    Endocrinology; 1988 Mar; 122(3):840-6. PubMed ID: 2963741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance receptors for atrial natriuretic petide in Milan hypertensive and normotensive rats.
    Aptel HB; Wannop DW; al-Busada K; Henderson IW
    J Hypertens; 1996 Apr; 14(4):461-8. PubMed ID: 8761895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with cushing's disease.
    Sala C; Ambrosi B; Morganti A
    J Clin Endocrinol Metab; 2001 May; 86(5):1957-61. PubMed ID: 11344191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.